$XWEL
XWELL Inc

2023 Q3 Form 10-Q Financial Statement

#000155837023014907 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $7.468M $8.175M $13.60M
YoY Change -30.44% -39.88% 49.55%
Cost Of Revenue $6.377M $6.985M $12.36M
YoY Change -31.72% -43.47% 60.46%
Gross Profit $1.091M $1.190M $1.240M
YoY Change -21.9% -4.03% -10.86%
Gross Profit Margin 14.61% 14.56% 9.12%
Selling, General & Admin $3.906M $5.100M $7.558M
YoY Change -39.41% -32.52% 62.68%
% of Gross Profit 358.02% 428.57% 609.52%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $590.0K $593.0K $1.501M
YoY Change -62.28% -60.49% 58.67%
% of Gross Profit 54.08% 49.83% 121.05%
Operating Expenses $4.769M $5.890M $7.558M
YoY Change -26.03% -22.07% 62.68%
Operating Profit -$10.48M -$4.724M -$7.767M
YoY Change 36.87% -39.18% 84.88%
Interest Expense $676.0K -$890.0K -$119.0K
YoY Change 3280.0% 647.9% -76.2%
% of Operating Profit
Other Income/Expense, Net -$198.0K -$120.0K -$196.0K
YoY Change 45.59% -38.78% -64.43%
Pretax Income -$9.978M -$5.679M -$7.925M
YoY Change 29.99% -28.34% 67.23%
Income Tax $0.00 $0.00 $2.000K
% Of Pretax Income
Net Earnings -$9.918M -$5.730M -$7.918M
YoY Change 38.15% -27.63% 77.26%
Net Earnings / Revenue -132.81% -70.09% -58.23%
Basic Earnings Per Share -$2.38 -$0.07 -$0.08
Diluted Earnings Per Share -$2.38 -$0.07 -$0.08
COMMON SHARES
Basic Shares Outstanding 83.49M 83.42M 95.35M
Diluted Shares Outstanding 4.174M 83.41M 95.35M

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $26.14M $31.90M $71.11M
YoY Change -47.09% -55.14% -30.62%
Cash & Equivalents $4.827M $6.378M $71.11M
Short-Term Investments $21.31M $25.50M
Other Short-Term Assets $1.663M $1.445M $1.362M
YoY Change -29.98% 6.09% -57.56%
Inventory $968.0K $845.0K $1.065M
Prepaid Expenses $1.419M $1.075M $1.315M
Receivables $1.193M $1.934M $832.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $29.96M $36.13M $74.37M
YoY Change -45.7% -51.42% -30.87%
LONG-TERM ASSETS
Property, Plant & Equipment $3.801M $3.867M $8.020M
YoY Change -53.09% -51.78% 67.89%
Goodwill $4.024M $4.024M
YoY Change 0.0%
Intangibles $2.174M $3.710M $4.986M
YoY Change -50.75% -25.59% 319.7%
Long-Term Investments
YoY Change
Other Assets $1.787M $1.715M $2.435M
YoY Change -18.96% -29.57% -12.0%
Total Long-Term Assets $14.59M $20.46M $27.00M
YoY Change -51.04% -24.22% 115.36%
TOTAL ASSETS
Total Short-Term Assets $29.96M $36.13M $74.37M
Total Long-Term Assets $14.59M $20.46M $27.00M
Total Assets $44.55M $56.59M $101.4M
YoY Change -47.57% -44.18% -15.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.511M $2.164M $9.300M
YoY Change -81.11% -76.73% 4.49%
Accrued Expenses $6.072M $6.300M $3.007M
YoY Change 124.89% 109.51% 15.21%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $8.157M $9.266M $12.54M
YoY Change -25.74% -26.11% -38.33%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $9.123M $10.30M $8.885M
YoY Change -27.02% 15.93% 45.68%
Total Long-Term Liabilities $9.123M $10.30M $8.885M
YoY Change -27.02% 15.93% 45.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.157M $9.266M $12.54M
Total Long-Term Liabilities $9.123M $10.30M $8.885M
Total Liabilities $17.28M $19.59M $21.43M
YoY Change -26.31% -8.58% -18.95%
SHAREHOLDERS EQUITY
Retained Earnings -$449.3M -$439.4M -$407.5M
YoY Change 8.35% 7.82% 0.82%
Common Stock $42.00K $833.0K $954.0K
YoY Change -94.95% -12.68% -9.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $19.40M $29.26M $71.43M
YoY Change
Total Liabilities & Shareholders Equity $44.55M $56.59M $101.4M
YoY Change -47.57% -44.18% -15.61%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$9.918M -$5.730M -$7.918M
YoY Change 38.15% -27.63% 77.26%
Depreciation, Depletion And Amortization $590.0K $593.0K $1.501M
YoY Change -62.28% -60.49% 58.67%
Cash From Operating Activities -$4.253M -$2.750M -$6.841M
YoY Change -51.62% -59.8% -505.75%
INVESTING ACTIVITIES
Capital Expenditures $397.0K $300.0K -$2.419M
YoY Change -77.05% -112.4% 45.37%
Acquisitions
YoY Change
Other Investing Activities $2.995M -$180.0K
YoY Change
Cash From Investing Activities $2.598M -$480.0K -$2.419M
YoY Change -250.17% -80.16% 45.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 148.0K -120.0K -2.586M
YoY Change -101.33% -95.36% 1844.36%
NET CHANGE
Cash From Operating Activities -4.253M -2.750M -6.841M
Cash From Investing Activities 2.598M -480.0K -2.419M
Cash From Financing Activities 148.0K -120.0K -2.586M
Net Change In Cash -1.507M -3.350M -11.85M
YoY Change -93.04% -71.72% 10572.07%
FREE CASH FLOW
Cash From Operating Activities -$4.253M -$2.750M -$6.841M
Capital Expenditures $397.0K $300.0K -$2.419M
Free Cash Flow -$4.650M -$3.050M -$4.422M
YoY Change -55.8% -31.03% -232.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83410562
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
95352025
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83378408
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
98458153
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
dei Entity Central Index Key
EntityCentralIndexKey
0001410428
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
83232262
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
83418535
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-34785
dei Entity Registrant Name
EntityRegistrantName
XWELL, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-4988129
dei Entity Address Address Line1
EntityAddressAddressLine1
254 West 31st Street
dei Entity Address Address Line2
EntityAddressAddressLine2
11th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10001
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
750-9595
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
XWEL
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
83487663
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6378000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19038000
CY2023Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
25526000
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
23153000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1934000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2858000
CY2023Q2 us-gaap Inventory Net
InventoryNet
845000
CY2022Q4 us-gaap Inventory Net
InventoryNet
1161000
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1445000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1122000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
36128000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
47332000
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
751000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
751000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3867000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3666000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3710000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4008000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6392000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8276000
CY2023Q2 us-gaap Goodwill
Goodwill
4024000
CY2022Q4 us-gaap Goodwill
Goodwill
4024000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1715000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2369000
CY2023Q2 us-gaap Assets
Assets
56587000
CY2022Q4 us-gaap Assets
Assets
70426000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2164000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2312000
CY2023Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
4597000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
5719000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2243000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2586000
CY2023Q2 us-gaap Deferred Revenue
DeferredRevenue
262000
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
339000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
9266000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10956000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10321000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11521000
CY2023Q2 us-gaap Liabilities
Liabilities
19587000
CY2022Q4 us-gaap Liabilities
Liabilities
22477000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
83418535
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
83232262
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
833000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
832000
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
468909000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
467740000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-439351000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-428112000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1128000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-534000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
29263000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
39926000
CY2023Q2 us-gaap Minority Interest
MinorityInterest
7737000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
8023000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
37000000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
47949000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56587000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
70426000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8175000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13597000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15238000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
37645000
CY2023Q2 us-gaap Cost Direct Labor
CostDirectLabor
4769000
CY2022Q2 us-gaap Cost Direct Labor
CostDirectLabor
5477000
us-gaap Cost Direct Labor
CostDirectLabor
9147000
us-gaap Cost Direct Labor
CostDirectLabor
10939000
CY2023Q2 xwel Cost Of Occupancy
CostOfOccupancy
961000
CY2022Q2 xwel Cost Of Occupancy
CostOfOccupancy
1262000
xwel Cost Of Occupancy
CostOfOccupancy
2174000
xwel Cost Of Occupancy
CostOfOccupancy
2330000
CY2023Q2 xwel Products And Other Operating Costs
ProductsAndOtherOperatingCosts
1255000
CY2022Q2 xwel Products And Other Operating Costs
ProductsAndOtherOperatingCosts
5618000
xwel Products And Other Operating Costs
ProductsAndOtherOperatingCosts
2205000
xwel Products And Other Operating Costs
ProductsAndOtherOperatingCosts
14135000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
6985000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
12357000
us-gaap Cost Of Revenue
CostOfRevenue
13526000
us-gaap Cost Of Revenue
CostOfRevenue
27404000
CY2023Q2 us-gaap Gross Profit
GrossProfit
1190000
CY2022Q2 us-gaap Gross Profit
GrossProfit
1240000
us-gaap Gross Profit
GrossProfit
1712000
us-gaap Gross Profit
GrossProfit
10241000
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
593000
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1501000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1180000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2765000
CY2023Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-18000
CY2022Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
52000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-18000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
52000
CY2023Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
204000
CY2022Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1222000
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
315000
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
2833000
CY2023Q2 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
204000
CY2022Q2 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
839000
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
913000
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1506000
CY2023Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
4895000
CY2022Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
5497000
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
10298000
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
13407000
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
5914000
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
9007000
us-gaap Costs And Expenses
CostsAndExpenses
12724000
us-gaap Costs And Expenses
CostsAndExpenses
20459000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4724000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7767000
us-gaap Operating Income Loss
OperatingIncomeLoss
-11012000
us-gaap Operating Income Loss
OperatingIncomeLoss
-10218000
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
105000
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
38000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
229000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
45000
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1141000
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1056000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5000
CY2023Q2 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
201000
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
478000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-120000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-193000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-147000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-509000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5679000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7925000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11508000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10687000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-5679000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-7927000
us-gaap Profit Loss
ProfitLoss
-11508000
us-gaap Profit Loss
ProfitLoss
-10689000
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
51000
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-9000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-269000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1512000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-5730000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-7918000
us-gaap Net Income Loss
NetIncomeLoss
-11239000
us-gaap Net Income Loss
NetIncomeLoss
-12201000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-5679000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-7927000
us-gaap Profit Loss
ProfitLoss
-11508000
us-gaap Profit Loss
ProfitLoss
-10689000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-464000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-105000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-594000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-146000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6143000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8032000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12102000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10835000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83410562
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83410562
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
95352025
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
95352025
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83378408
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83378408
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
98458153
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
98458153
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
47949000
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
22000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
612000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-5829000
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-119000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
42591000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
626000
CY2023Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
120000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-418000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-5679000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
37000000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
99935000
CY2022Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
906000
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
73000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1543000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-2762000
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
11095000
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-41000
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
824000
CY2022Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
200000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
87789000
CY2022Q2 xwel Adjustments To Additional Paid In Capital Grant Of Stock Options For Services
AdjustmentsToAdditionalPaidInCapitalGrantOfStockOptionsForServices
15000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1320000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-7927000
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1021000
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-105000
CY2022Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
132000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
79939000
us-gaap Profit Loss
ProfitLoss
-11508000
us-gaap Profit Loss
ProfitLoss
-10689000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1180000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2765000
us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
1103000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-18000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
52000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
309000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
806000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
828000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
15000
us-gaap Share Based Compensation
ShareBasedCompensation
1238000
us-gaap Share Based Compensation
ShareBasedCompensation
2863000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-33000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-430000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-316000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-684000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-924000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-186000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-65000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
295000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-77000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1027000
xwel Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-2592000
xwel Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-2803000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
185000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1520000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8618000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8615000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1235000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4062000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
2064000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
4853000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
471000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
283000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3770000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9198000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
12116000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
200000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
22000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
73000
xwel Repayment Of Paycheck Protection Program
RepaymentOfPaycheckProtectionProgram
3584000
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
120000
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
956000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-142000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-16529000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-130000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-56000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12660000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-34398000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19789000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106257000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7129000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71859000
us-gaap Interest Paid
InterestPaid
10000
us-gaap Income Taxes Paid
IncomeTaxesPaid
122000
us-gaap Income Taxes Paid
IncomeTaxesPaid
2000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
397000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
231000
us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
906000
us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 1. Business, Basis of Presentation and Liquidity</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Overview</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">On October 25, 2022, the Company changed its name to XWELL, Inc. (“XWELL” or the “Company”) from XpresSpa Group, Inc. The Company’s common stock, par value $0.01 per share, which had previously been listed under the trading symbol “XSPA” on the Nasdaq Capital Market, now trades under the trading symbol “XWEL” since the opening of the trading market on October 25, 2022. <span style="background:#ffffff;"> The Company filed an amended and restated certificate of incorporation with the Delaware Secretary of State on October 24, 2022 (the “Amended and Restated Certificate”) reflecting the name change. </span> Rebranding to XWELL aligned the Company’s corporate strategy to build a pure-play health and wellness services company, in both the airport and off airport marketplaces.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;"><span style="font-size:10pt;">XWELL is a global travel health and wellness services holding company. XWELL currently has </span><span style="font-size:10pt;">four</span><span style="font-size:10pt;"> reportable operating segments: XpresSpa</span><sup style="font-size:5.62pt;line-height:100%;top:0pt;vertical-align:top;background:#ffffff;">®</sup><span style="font-size:10pt;">, Xpres</span><span style="font-size:10pt;">Test</span><sup style="font-size:5.62pt;line-height:100%;top:0pt;vertical-align:top;background:#ffffff;">®</sup><span style="font-size:10pt;">, Treat</span><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;background:#ffffff;">™</sup><span style="font-size:10pt;">, and HyperPointe which was acquired in January 2022.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">XpresSpa</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">XWELL’s subsidiary, XpresSpa Holdings, LLC (“XpresSpa”) has been a global airport retailer of spa services through its XpresSpa spa locations, offering travelers premium spa services, including massage, nail and skin care, as well as spa and travel products.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of June 30, 2023, there were <span style="background:#ffffff;">25</span> operating XpresSpa domestic locations. During 2022, the Company sold one<span style="background:#ffffff;"> location in Austin-Bergstrom International Airport to its franchisee which now operates both locations at this airport. </span>As the Company continues to monitor fluctuating airport volumes, the Company will also continue to review operating hours to optimize revenue opportunity. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Company also had 10 international locations operating as of June 30, 2023, including two XpresSpa locations in Dubai International Airport in the United Arab Emirates, three XpresSpa locations in Schiphol Amsterdam Airport in the Netherlands and five XpresSpa locations in Istanbul Airport in Turkey.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">XpresTest</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Company, in partnership with certain COVID-19 testing partners, successfully launched its XpresCheck Wellness Centers through its XpresTest, Inc. subsidiary (“XpresTest”), offering testing services, also in airports.  During 2022, as countries continued to relax their testing requirements resulting in rapid decline of testing volumes at the Company’s  XpresCheck locations, the Company closed all but one XpresCheck Wellness Center. As of June 30, 2023, we have closed all XpresCheck locations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">XpresTest began conducting biosurveillance monitoring with the Centers for Disease Control and Prevention (CDC) in collaboration with Concentric by Ginkgo in 2021 and on January 31, 2022, the Company announced the extension of the initial program, bringing the total contract to $5,534. As of August 2022, the program was renewed in partnership with Ginkgo BioWorks for a new two-year contract term which represents approximately $7,331 in revenue (for the first year) for the XpresTest segment. On August 11, 2023, the revenue for the second year was determined to be approximately $6,000.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Treat</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Treat segment, which is operating through XWELL’s subsidiary Treat, Inc. (“Treat”) is a travel health and wellness brand that provides access to health and wellness services for travelers at on-site centers (currently located in JFK International Airport and in Salt Lake City International Airport).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In 2022, the Company’s Treat brand opened new locations in Phoenix Sky Harbor International Airport (pre-security) and Salt Lake City International Airport. With respect to these locations in Phoenix and Salt Lake City, agreements had already been executed with the airports and the decision was made to convert these locations to Treat.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">By the third quarter of 2022, it became clear that the Treat business required a change in strategy and as a result, the Company began to retool the offerings within the Treat locations by providing additional retail as part of our retail strategy expansion as well as lay the foundation to bring more spa-like services into the Treat location in an attempt to unify our core offering.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">By the fourth quarter of 2022, the decision was made to close the pre-security Treat location at Phoenix Sky Harbor Airport. As of June 30, 2023, the Treat brand operates at two locations (JFK International Airport and Salt Lake City International Airport).  These remaining Treat locations offer a full retail product offering and a suite of wellness and spa services.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">HyperPointe</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company’s HyperPointe segment, which the Company acquired in January 2022, provides a broad range of service and support options for our customers, including technical support services and advanced services.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Basis of Presentation and Principles of Consolidation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and the instructions to Article 8-03 of Regulation S-X, and should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, as amended. The condensed consolidated balance sheet as of December 31, 2022 was derived from the audited annual financial statements but does not include all information required by GAAP for annual financial statements. The financial statements include the accounts of the Company, all entities that are wholly owned by the Company, and all entities in which the Company has a controlling financial interest as well as variable interest entities in which we are the primary beneficiaries. All adjustments that, in the opinion of management, are necessary for a fair presentation for the periods presented have been reflected by the Company. Such adjustments are of a normal, recurring nature. The results of operations for the three and six months ended June 30, 2023 are not necessarily indicative of the results that may be expected for the entire fiscal year or for any other interim period. All significant intercompany balances and transactions have been eliminated in consolidation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Liquidity and Financial Condition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of June 30, 2023, the Company had cash and cash equivalents, excluding restricted cash, of $6,378, $25,526 in marketable securities, and total current assets of $36,128. The Company’s total current liabilities balance, which includes accounts payable, deferred revenue, accrued expenses, and operating lease liabilities was approximately $9,266 as of June 30, 2023 and $10,956 as of December 31, 2022. The working capital surplus was $26,862 as of June 30, 2023, compared to a working capital surplus of $36,376 as of December 31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company has significantly reduced operating and overhead expenses since the second half of 2022, while it continues to focus on returning to overall profitability. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="background:#ffffff;">The Company has taken actions to improve its overall cash position and access to liquidity through equity offerings and debt retirements, by exploring valuable strategic partnerships, right sizing its corporate structure and streamlining its operations.</span></p>
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6378000
CY2023Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
25526000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
36128000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
9266000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10956000
CY2023Q2 xwel Working Capital
WorkingCapital
26862000
CY2022Q4 xwel Working Capital
WorkingCapital
36376000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">(e) Reclassification</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Certain balances in the condensed consolidated financial statements for the three and six months ended June 30, 2022 have been reclassified to conform to the presentation in the condensed consolidated financial statements for the three and six months ended June 30, 2023, primarily the separate classification and presentation of accounts payable, gross profits, advertising and promotion expense, IT/Hosting services, and realized and unrealized foreign exchange loss. The above separation affected accounts payable, accrued expenses and other, general and administrative expenses, and other non-operating expense, net in the comparative 2022 financial statements. Such reclassifications did not have a material impact on the unaudited condensed consolidated financial statements.</p>
CY2023Q2 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
3552000
CY2022Q4 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
16069000
CY2023Q2 xwel Cash Held In Overseas Accounts
CashHeldInOverseasAccounts
2686000
CY2023Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-5730000
CY2022Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-7918000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-11239000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-12201000
CY2023Q2 xwel Net Loss Attributable To Common Shareholders
NetLossAttributableToCommonShareholders
-5730000
CY2022Q2 xwel Net Loss Attributable To Common Shareholders
NetLossAttributableToCommonShareholders
-7918000
xwel Net Loss Attributable To Common Shareholders
NetLossAttributableToCommonShareholders
-11239000
xwel Net Loss Attributable To Common Shareholders
NetLossAttributableToCommonShareholders
-12201000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83410562
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
95352025
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83378408
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
98458153
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7978335
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
34295658
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7978335
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
34295658
CY2023Q2 us-gaap Cash
Cash
3550000
CY2022Q4 us-gaap Cash
Cash
16344000
CY2023Q2 xwel Currency Other Than Us Dollars
CurrencyOtherThanUsDollars
2686000
CY2022Q4 xwel Currency Other Than Us Dollars
CurrencyOtherThanUsDollars
2562000
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
751000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
751000
CY2023Q2 us-gaap Credit And Debit Card Receivables At Carrying Value
CreditAndDebitCardReceivablesAtCarryingValue
142000
CY2022Q4 us-gaap Credit And Debit Card Receivables At Carrying Value
CreditAndDebitCardReceivablesAtCarryingValue
132000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7129000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19789000
CY2022Q4 xwel Cash Held In Overseas Accounts
CashHeldInOverseasAccounts
2562000
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1075000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1074000
CY2023Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
291000
CY2023Q2 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
79000
CY2022Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
48000
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1445000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1122000
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6498000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2788000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3710000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6352000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2344000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4008000
CY2023Q2 xwel Amortization And Impairment Of Intangible Assets
AmortizationAndImpairmentOfIntangibleAssets
377000
CY2022Q2 xwel Amortization And Impairment Of Intangible Assets
AmortizationAndImpairmentOfIntangibleAssets
471000
xwel Amortization And Impairment Of Intangible Assets
AmortizationAndImpairmentOfIntangibleAssets
759000
xwel Amortization And Impairment Of Intangible Assets
AmortizationAndImpairmentOfIntangibleAssets
864000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
834000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1666000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
502000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
393000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
77000
CY2023Q2 xwel Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
238000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3710000
CY2023Q2 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
449000
CY2022Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
963000
CY2023Q2 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
1749000
CY2022Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
2008000
CY2023Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
552000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
573000
CY2023Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
90000
CY2022Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
160000
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
779000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
754000
CY2023Q2 xwel Accrued Liability For Unredeemed Gift Cards
AccruedLiabilityForUnredeemedGiftCards
495000
CY2022Q4 xwel Accrued Liability For Unredeemed Gift Cards
AccruedLiabilityForUnredeemedGiftCards
496000
CY2023Q2 xwel Credit Card Processing Fees
CreditCardProcessingFees
35000
CY2022Q4 xwel Credit Card Processing Fees
CreditCardProcessingFees
33000
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
448000
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
732000
CY2023Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
4597000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
5719000
us-gaap Operating Lease Payments
OperatingLeasePayments
1839000
us-gaap Operating Lease Payments
OperatingLeasePayments
2031000
xwel Right Of Use Asset Obtained In Exchange For New And Modified Operating Lease Liability
RightOfUseAssetObtainedInExchangeForNewAndModifiedOperatingLeaseLiability
3273000
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
104000
CY2023Q2 us-gaap Leveraged Lease Investment
LeveragedLeaseInvestment
1549000
CY2022Q4 us-gaap Leveraged Lease Investment
LeveragedLeaseInvestment
1973000
CY2023Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
95000
CY2022Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
292000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1715000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2369000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1611000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3002000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2649000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1634000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1511000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1132000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3341000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
14880000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2316000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
12564000
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y1M24D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0740
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
598000
us-gaap Operating Lease Expense
OperatingLeaseExpense
1259000
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
349000
us-gaap Operating Lease Expense
OperatingLeaseExpense
620000
CY2023Q2 us-gaap Variable Lease Payment
VariableLeasePayment
365000
CY2022Q2 us-gaap Variable Lease Payment
VariableLeasePayment
324000
us-gaap Variable Lease Payment
VariableLeasePayment
711000
us-gaap Variable Lease Payment
VariableLeasePayment
689000
CY2023Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
71000
CY2020Q3 xwel Number Of Equal Quarterly Vesting Installment
NumberOfEqualQuarterlyVestingInstallment
4
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
626000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1320000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1238000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2863000
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2437000
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2506000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4830029
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2886388
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.40
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
49919
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
1.32
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
24801
xwel Share Based Compensation Arrangement By Share Based Payment Award Vested Options Expired Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedOptionsExpiredWeightedAverageGrantDateFairValue
11.75
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7641697
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.37
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3962957
xwel Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue
1.66
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
xwel Effective Income Tax Rate Discontinued Operations
EffectiveIncomeTaxRateDiscontinuedOperations
0
CY2023Q2 xwel Effective Income Tax Rate Discontinued Operations
EffectiveIncomeTaxRateDiscontinuedOperations
0
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2023Q2 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4
CY2023Q2 us-gaap Revenues
Revenues
8175000
CY2022Q2 us-gaap Revenues
Revenues
13597000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4724000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7767000
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
593000
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1501000
us-gaap Revenues
Revenues
15238000
us-gaap Revenues
Revenues
37645000
us-gaap Operating Income Loss
OperatingIncomeLoss
-11012000
us-gaap Operating Income Loss
OperatingIncomeLoss
-10218000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1180000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2765000
CY2023Q2 xwel Property Plant Equipment Capital Expenditure
PropertyPlantEquipmentCapitalExpenditure
1560000
CY2022Q2 xwel Property Plant Equipment Capital Expenditure
PropertyPlantEquipmentCapitalExpenditure
3432000
CY2023Q2 xwel Long Lived Assets
LongLivedAssets
16655000
CY2022Q4 xwel Long Lived Assets
LongLivedAssets
18794000
CY2023Q2 us-gaap Assets
Assets
56587000
CY2022Q4 us-gaap Assets
Assets
70426000

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001558370-23-014907-index-headers.html Edgar Link pending
0001558370-23-014907-index.html Edgar Link pending
0001558370-23-014907.txt Edgar Link pending
0001558370-23-014907-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xwel-20230630.xsd Edgar Link pending
xwel-20230630x10q.htm Edgar Link pending
xwel-20230630xex31d1.htm Edgar Link pending
xwel-20230630xex31d2.htm Edgar Link pending
xwel-20230630xex32.htm Edgar Link pending
xwel-20230630_cal.xml Edgar Link unprocessable
xwel-20230630_def.xml Edgar Link unprocessable
xwel-20230630_pre.xml Edgar Link unprocessable
xwel-20230630_lab.xml Edgar Link unprocessable
xwel-20230630x10q_htm.xml Edgar Link completed